TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 105 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2015. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $28,000 | +21.7% | 20,583 | 0.0% | 0.00% | – |
| Q4 2018 | $23,000 | -59.6% | 20,583 | 0.0% | 0.00% | – |
| Q3 2018 | $57,000 | -21.9% | 20,583 | 0.0% | 0.00% | – |
| Q2 2018 | $73,000 | +15.9% | 20,583 | 0.0% | 0.00% | – |
| Q1 2018 | $63,000 | -51.5% | 20,583 | 0.0% | 0.00% | – |
| Q4 2017 | $130,000 | -7.8% | 20,583 | 0.0% | 0.00% | – |
| Q3 2017 | $141,000 | -4.1% | 20,583 | 0.0% | 0.00% | – |
| Q2 2017 | $147,000 | -8.7% | 20,583 | +17.8% | 0.00% | – |
| Q1 2017 | $161,000 | +130.0% | 17,479 | 0.0% | 0.00% | – |
| Q4 2016 | $70,000 | +4.5% | 17,479 | 0.0% | 0.00% | – |
| Q3 2016 | $67,000 | -10.7% | 17,479 | 0.0% | 0.00% | – |
| Q2 2016 | $75,000 | -7.4% | 17,479 | 0.0% | 0.00% | – |
| Q1 2016 | $81,000 | -53.7% | 17,479 | 0.0% | 0.00% | – |
| Q4 2015 | $175,000 | +34.6% | 17,479 | 0.0% | 0.00% | – |
| Q3 2015 | $130,000 | -99.4% | 17,479 | -96.0% | 0.00% | -100.0% |
| Q2 2015 | $20,610,000 | +119.8% | 434,454 | +69.8% | 0.05% | +123.8% |
| Q1 2015 | $9,375,000 | +1297.2% | 255,846 | +1414.9% | 0.02% | +2000.0% |
| Q4 2014 | $671,000 | +99.1% | 16,889 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $337,000 | +47.8% | 16,889 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $228,000 | – | 16,889 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 664,000 | $2,543,000 | 0.82% |
| GREAT POINT PARTNERS LLC | 452,375 | $1,733,000 | 0.44% |
| Clearline Capital LP | 267,915 | $1,026,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,149,000,000 | 0.18% |
| Rock Springs Capital Management LP | 662,500 | $2,537,000 | 0.16% |
| Eventide Asset Management | 600,000 | $2,298,000 | 0.14% |
| Granahan Investment Management | 657,496 | $2,518,000 | 0.08% |
| Candriam S.C.A. | 374,000 | $1,432,000 | 0.03% |
| Tekla Capital Management LLC | 192,322 | $737,000 | 0.03% |
| DOW CHEMICAL CO /DE/ | 65,000 | $249,000 | 0.02% |